Accessibility Menu
Vaso Stock Quote

Vaso (OTC: VASO)

$0.11
(-1.0%)
-0.00
Price as of October 22, 2025, 3:59 p.m. ET

KEY DATA POINTS

Current Price
$0.11
Daily Change
(-1.0%) $0.00
Day's Range
$0.11 - $0.12
Previous Close
$0.11
Open
$0.11
Beta
0.41
Volume
4,300
Average Volume
94,715
Market Cap
20.2M
Market Cap / Employee
$0.12M
52wk Range
$0.11 - $0.17
Revenue
-
Gross Margin
0.60%
Dividend Yield
N/A
EPS
-$0
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Vaso Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
VASO-28.02%+380.27%+36.87%-96%
S&P+15.06%+95.03%+14.29%+1,542%

Vaso Company Info

Vaso Corp. engages in the healthcare equipment and information technology industries. It operates through the following segments: Information Technology (IT), Professional Sales Service, and Equipment. The IT segment focuses on healthcare IT and managed network technology services. The Professional Sales Service segment is involved in selling healthcare capital equipment. The Equipment segment consists of designing, manufacturing, selling, and servicing proprietary medical devices. The company was founded by John C. K. Hui and William Cross in July 1987 and is headquartered in Plainview, NY.

Financial Health

General

Q2 2025YOY Change
Revenue$19.96M-1.3%
Gross Profit$11.80M-2.9%
Gross Margin59.11%-1.0%
Market Cap$22.67M-56.2%
Market Cap / Employee$0.08M0.0%
Employees298-0.7%
Net Income-$0.20M-117.1%
EBITDA-$0.23M-117.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$32.56M26.9%
Accounts Receivable$8.83M22.4%
Inventory0.9-22.9%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.89M-29.2%
Short Term Debt$2.06M79.9%

Ratios

Q2 2025YOY Change
Return On Assets-0.39%-3.5%
Return On Invested Capital24.79%1.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$6.29M154.4%
Operating Free Cash Flow$6.80M143.7%

Valuation

MetricQ1 2024Q2 2024Q4 2024Q1 2025YoY Change
Price to Earnings16.5823.0522.2024.58120.78%
Price to Book1.240.820.920.85-57.94%
Price to Sales0.410.240.290.26-59.78%
Price to Tangible Book Value3.432.472.422.43-59.60%
Price to Free Cash Flow TTM50.5311.5210.443.62-64.77%
Enterprise Value to EBITDA22.94-1.14-2.1930.3140.75%
Free Cash Flow Yield2.0%8.7%9.6%27.6%183.82%
Return on Equity-0.5%3.5%4.0%-1.1%-113.08%
Total Debt$2.19M$2.38M$2.15M$2.95M22.83%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.